NPHS1 and crescentic glomerulonephritis: In this sense, in experimental crescentic glomerulonephritis, miR-155 participated in Th17 immune response and tissue injury (Krebs et al., 2013), and their deficiency attenuated the renal damage in hyperglycemia-induced nephropathy by promoting nephrin acetylation (Lin et al., 2015).